nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bradykinin and the therapeutic actions of angiotensin-converting enzyme inhibitors
|
Berkenboom, Guy |
|
1998 |
82 |
9S2 |
p. 11S-13S nvt p. |
artikel |
2 |
Cardioprotective effects of postmenopausal hormone treatment
|
Espeland, Mark A. |
|
1998 |
82 |
9S2 |
p. 37S-39S nvt p. |
artikel |
3 |
Cardiovascular effects of soybean phytoestrogens
|
St. Clair, Richard |
|
1998 |
82 |
9S2 |
p. 40S-42S nvt p. |
artikel |
4 |
Disruption of the endothelial nitric oxide synthase gene: effect on vascular response to injury
|
Huang, Paul L. |
|
1998 |
82 |
9S2 |
p. 57S-59S nvt p. |
artikel |
5 |
Effect of the angiotensin-(1-7) peptide on nitric oxide release
|
Brosnihan, K.Bridget |
|
1998 |
82 |
9S2 |
p. 17S-19S nvt p. |
artikel |
6 |
Effect of treatment on survival in an animal model of chronic heart failure
|
Bastien, Natacha |
|
1998 |
82 |
9S2 |
p. 50S-52S nvt p. |
artikel |
7 |
Effects of antihypertensive agents on endothelial dysfunction: rationale for the brachial artery normalization of forearm function study
|
Charbonneau, François |
|
1998 |
82 |
9S2 |
p. 34S-36S nvt p. |
artikel |
8 |
Effects of aspirin on endothelial dysfunction in atherosclerosis
|
Quyyumi, Arshed A. |
|
1998 |
82 |
9S2 |
p. 31S-33S nvt p. |
artikel |
9 |
Factors involved in the maintenance of endothelial function
|
Drexler, Helmut |
|
1998 |
82 |
9S2 |
p. 3S-4S nvt p. |
artikel |
10 |
Gene therapy for hypertension: antisense inhibition with adeno-associated viral vector delivery targeting angiotensin II type 1 receptor messenger ribonucleic acid
|
Phillips, M.Ian |
|
1998 |
82 |
9S2 |
p. 60S-62S nvt p. |
artikel |
11 |
Hypertension, heart failure, and endothelial function
|
Drexler, Helmut |
|
1998 |
82 |
9S2 |
p. 20S-22S nvt p. |
artikel |
12 |
Impact of endothelin-1 on vascular structure and function
|
Stewart, Duncan J. |
|
1998 |
82 |
9S2 |
p. 14S-16S nvt p. |
artikel |
13 |
Introduction
|
Pepine, Carl J. |
|
1998 |
82 |
9S2 |
p. 1S-2S nvt p. |
artikel |
14 |
Modulation of arterial thrombosis by angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade
|
Mehta, Jawahar L. |
|
1998 |
82 |
9S2 |
p. 53S-56S nvt p. |
artikel |
15 |
Nutriceuticals for cardiovascular health
|
Cooke, John P |
|
1998 |
82 |
9S2 |
p. 43S-46S nvt p. |
artikel |
16 |
Overview of angiotensin II-receptor antagonists
|
Pitt, Bertram |
|
1998 |
82 |
9S2 |
p. 47S-49S nvt p. |
artikel |
17 |
Potential mechanisms for the effect of angiotensin-converting enzyme inhibitors on endothelial dysfunction: the role of nitric oxide
|
Cannon III, Richard O. |
|
1998 |
82 |
9S2 |
p. 8S-10S nvt p. |
artikel |
18 |
Primary and secondary prevention of coronary artery disease: trials of lipid lowering with statins
|
Pearson, Thomas A |
|
1998 |
82 |
9S2 |
p. 28S-30S nvt p. |
artikel |
19 |
The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: potential role in myocardial ischemia
|
Pepine, Carl J |
|
1998 |
82 |
9S2 |
p. 23S-27S nvt p. |
artikel |
20 |
The role of tissue angiotensin-converting enzyme (ACE): studies of ACE mutant mice
|
Bernstein, Kenneth E. |
|
1998 |
82 |
9S2 |
p. 5S-7S nvt p. |
artikel |
21 |
Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis
|
Isner, Jeffrey M. |
|
1998 |
82 |
9S2 |
p. 63S-64S nvt p. |
artikel |